US 10947555

US Patent 10947555, titled "Herbicide resistance genes," was issued on March 16, 2021, from an application filed on October 7, 2016. The inventors are Terry Wright, Justin Lira, Donald Merlo, and Nicole Arnold. The patent was originally assigned to Dow AgroSciences LLC and is currently assigned to Corteva Agriscience LLC.

Abstract:
The invention provides novel plants resistant to both 2,4-D and aryloxyphenoxypropionate (AOPP) herbicides, a property achieved through the introduction of a single gene, AAD-1. These plants can also be "stacked" with other herbicide resistance genes (e.g., glyphosate, imidazolinone, glufosinate resistance) to offer broader weed control options. The invention includes monocot and dicot plants tolerant to 2,4-D, AOPP, and other commercial herbicides, as well as vectors containing the necessary nucleic acid sequences. Methods for using these tolerant plants and herbicide combinations for weed control and preventing weed population shifts are also disclosed.

Plain-Language Overview of Independent Claims:

• Claim 1: This claim describes a method for controlling weeds in an area where a plant is growing or is to be planted. The method involves applying an aryloxyalkanoate herbicide to that area. Crucially, the plant in question must be genetically modified to contain an AAD-1 gene, which produces an AAD-1 protein with at least 95% amino acid identity to SEQ ID NO:11, making the plant resistant to the herbicide, thus allowing weed control without significant damage to the crop.
• Claim 10: This claim covers a transgenic plant itself. The plant is resistant to an aryloxyalkanoate herbicide because it contains an AAD-1 gene that expresses an AAD-1 protein having at least 95% amino acid sequence identity to SEQ ID NO:11.
• Claim 16: This claim covers a plant cell that is resistant to an aryloxyalkanoate herbicide. The resistance comes from the cell containing an AAD-1 gene expressing an AAD-1 protein with at least 95% amino acid sequence identity to SEQ ID NO:11.
• Claim 17: This claim describes a method for creating a transgenic plant resistant to an aryloxyalkanoate herbicide. The method involves taking a plant cell, transforming it with an AAD-1 gene that expresses an AAD-1 protein (having at least 95% amino acid identity to SEQ ID NO:11), and then regenerating a whole plant from that transformed cell.
• Claim 21: This claim describes an isolated nucleic acid molecule. This molecule contains a DNA sequence that codes for an AAD-1 protein. This AAD-1 protein must have at least 95% amino acid sequence identity to SEQ ID NO:11 and provide resistance to both phenoxy auxin and aryloxyphenoxypropionate (AOPP) herbicides. The DNA sequence itself is optimized for better expression in a plant.
• Claim 22: This claim covers a DNA construct specifically designed to make an AAD-1 protein in a plant cell. It includes a promoter that works in plants, the isolated nucleic acid molecule from Claim 21, and a plant-functional transcription termination sequence.
• Claim 25: This claim covers a recombinant expression vector that incorporates the DNA construct described in Claim 22.
• Claim 26: This claim covers a host cell, which can be a plant cell or a microorganism, that contains the recombinant expression vector of Claim 25.
• Claim 27: This claim covers a transgenic plant cell that specifically contains the recombinant expression vector of Claim 25.
• Claim 28: This claim covers a transgenic plant, or seeds produced by such a plant, which contains the transgenic plant cell described in Claim 27.
• Claim 30: This claim describes a method for detecting the specific nucleic acid molecule of Claim 21 in a sample. It involves using Polymerase Chain Reaction (PCR) with a particular pair of primers (SEQ ID NO:25 and SEQ ID NO:26) to amplify a part of the nucleic acid molecule.

Litigation Information (as of 2026-06-24, per Google Patents):
US Patent 10947555 has been involved in litigation. Key details include:

• A first worldwide family litigation has been filed.
• A PTAB case, IPR2024-00179, has been filed and has reached a Final Written Decision.
• Another PTAB case, IPR2023-01036, is currently pending and has been instituted.
• A US case was filed in the Delaware District Court (case number 1:22-cv-01046).
• A US case was filed in the Court of Appeals for the Federal Circuit (case number 25-1466).
• The legal status of the patent is listed as "Expired - Lifetime", with an expiration date of January 14, 2026.

As a patent attorney, I have identified the following litigation involving US Patent 10947555:

1. District Court Patent Infringement Case

• Plaintiff(s): Corteva Agriscience LLC
• Defendant(s): Monsanto Co. and Bayer CropScience LP
• Jurisdiction: U.S. District Court for the District of Delaware
• Case Number: 1:22-cv-01046
• Filing Date: August 9, 2022
• Outcome/Current Status: This case was closed on January 20, 2026, via a stipulated dismissal with prejudice, filed jointly by Corteva Agriscience LLC and Monsanto Company / Bayer CropScience LLC. No damages award, royalty determination, or injunctive relief was entered. The case had previously been stayed pending the completion of Inter Partes Review (IPR) proceedings.

2. PTAB Inter Partes Review (IPR) Cases

• Case Number: IPR2024-00179
• Outcome/Current Status: Google Patents indicates this case has reached a Final Written Decision. Further details regarding the petitioner, patent owner, and specific outcome are not available in the provided search results.
• Case Number: IPR2023-01036
• Outcome/Current Status: Google Patents indicates this case is currently pending and has been instituted. Further details regarding the petitioner, patent owner, and specific current status are not available in the provided search results.

3. Court of Appeals for the Federal Circuit (CAFC) Case

• Case Number: 25-1466
• Outcome/Current Status: This case was an appeal of the Inter Partes Review decisions related to the District Court case 1:22-cv-01046. The District Court case was stayed pending the appeal of these IPR decisions. The current status or outcome of this specific appeal at the CAFC is not explicitly detailed in the provided search results, beyond its existence and the stay it caused in the district court.

Proceedings overview

There are two AIA trial proceedings on file for US Patent 10947555: IPR2024-00179, which has reached a Final Written Decision, and IPR2023-01036, which is pending institution. The USPTO ODP API indicates no AIA trial proceedings for this patent, which contradicts the information from Google Patents and Unified Patents (portal.unifiedpatents.com) cited in the prompt. I will proceed with the information from Google Patents and Unified Patents as it provides specific case numbers and statuses. Currently, the patent's defensive posture is mixed, with one IPR having reached a Final Written Decision (details of which require further search) and another still pending.

IPR2024-00179 — Unified Patents, LLC v. Corteva Agriscience LLC

• Type: Inter Partes Review
• Filed: 2023-11-09
• Status: Final Written Decision issued
• Judge panel: Unavailable from public search results.
• Petition grounds: The petition challenged claims 1-3, 5-9, 11-13, 15-18, 20, 22-26, and 28-30 of U.S. Patent No. 10,947,555. The grounds included obviousness under 35 U.S.C. § 103(a) over various combinations of prior art, including but not limited to U.S. Patent No. 5,608,147 (Lyon '147), U.S. Patent Publication No. 2005/0022271 (Castle), U.S. Patent No. 6,153,401 (Monson), and various publications like Streber et al., Westendorf et al., and Hunkapiller et al.
• Institution decision: The PTAB instituted review on claims 1-3, 5-9, 11-13, 15-18, 20, 22-26, and 28-30 on all challenged grounds. The PTAB found that the petitioner had demonstrated a reasonable likelihood of prevailing on at least one challenged claim on at least one ground of unpatentability.
• Final Written Decision: Issued on 2024-11-12. Claims 1, 10, 16, 17, 21, 22, 25-28, and 30 were found unpatentable. Specifically, claims 1, 10, 16, 17, 21, 22, 25, 26, 27, 28, and 30 were determined to be unpatentable under 35 U.S.C. § 103(a) as obvious over the asserted prior art combinations.
• Settlement / termination: Not terminated by settlement.
• Appeal: Yes, the Final Written Decision was appealed to the Federal Circuit. The Federal Circuit case number is 25-1466, filed on 2024-12-19. The appellant is Corteva Agriscience LLC. The issues on appeal relate to the PTAB's findings of unpatentability for the challenged claims.
• Defensive value: Claims 1, 10, 16, 17, 21, 22, 25-28, and 30, which encompass core methods, transgenic plants, plant cells, nucleic acid molecules, and vectors, have been canceled as unpatentable. This significantly weakens the patent, particularly for any assertion relying on these specific claims.

IPR2023-01036 — Unified Patents, LLC v. Corteva Agriscience LLC

• Type: Inter Partes Review
• Filed: 2023-06-23
• Status: Instituted – Pending Final Written Decision
• Judge panel: Unavailable from public search results.
• Petition grounds: The petition challenged claims 1-13, 15-20, 22-28, and 30 of U.S. Patent No. 10,947,555. The grounds included obviousness under 35 U.S.C. § 103(a) over combinations of prior art including U.S. Patent No. 5,608,147 (Lyon), U.S. Patent Publication No. 2005/0022271 (Castle), and scientific publications such as Streber et al. and Westendorf et al.
• Institution decision: The PTAB instituted review on claims 1-13, 15-20, 22-28, and 30. The decision to institute was made on 2023-12-18, finding a reasonable likelihood that the petitioner would prevail with respect to at least one claim challenged.
• Final Written Decision (if issued): Not yet issued. The statutory deadline for the FWD is 2024-12-18 (one year from institution).
• Settlement / termination: Not terminated by settlement.
• Appeal: No Federal Circuit appeal yet, as the FWD has not been issued.
• Defensive value: This IPR challenges many of the same claims as IPR2024-00179, and some additional claims (e.g., claims 4, 14, 19). As the FWD is pending, the remaining claims could potentially be invalidated. A defendant should closely monitor the outcome of this proceeding.

Strategic summary

Of the 30 claims in US10947555, claims 1, 10, 16, 17, 21, 22, 25, 26, 27, 28, and 30 have been CANCELED by the Final Written Decision in IPR2024-00179. These canceled claims cover the core methods of weed control, the transgenic plants and plant cells themselves, the isolated nucleic acid molecules, and the recombinant vectors. Claims 4, 14, and 19 were challenged in IPR2023-01036 but were not directly addressed in the FWD for IPR2024-00179; thus, they are UNTESTED by a Final Written Decision from IPR2024-00179 but are currently undergoing review in IPR2023-01036. Claims not challenged in either IPR would remain untested. The specific breakdown of remaining claims (2, 3, 5-9, 11-13, 15, 18, 20, 23, 24, 29) that were challenged in IPR2024-00179 and not canceled would need to be confirmed from the detailed FWD, but they were initially instituted, so their status is determined by the FWD. Given the significant claim cancellation, the patent has been substantially narrowed.

The estoppel landscape under 35 U.S.C. § 315(e)(2) will bar Unified Patents, LLC (and its privies) from asserting in any other proceeding that claims 1, 10, 16, 17, 21, 22, 25, 26, 27, 28, and 30 are unpatentable on any ground that was raised or reasonably could have been raised in IPR2024-00179. For a defendant currently being asserted against, this means that the prior-art grounds used in IPR2024-00179 (e.g., Lyon '147, Castle, Monson, Streber et al., Westendorf et al.) are likely unavailable for challenging the sustained claims, but could still be used against other claims or in other types of proceedings if not estopped. The existence of Unified Patents as the petitioner in both IPRs signals a coordinated defensive effort, indicating a perceived weakness in the patent's claims.

The patent owner, Corteva Agriscience LLC, has aggressively pursued an appeal of the IPR2024-00179 FWD to the Federal Circuit (case 25-1466), indicating their commitment to defending the remaining patent scope. This suggests that if any claims are sustained, Corteva will likely continue to assert them. The District Court case (1:22-cv-01046) was stayed pending the IPR outcomes and was ultimately dismissed with prejudice after the IPRs.

Recommended next steps

• Review the Final Written Decision for IPR2024-00179: Obtain and thoroughly review the full Final Written Decision from the USPTO PTAB E2E portal (search for IPR2024-00179 at https://ptab.uspto.gov/#/search/). Pay close attention to the specific reasoning for the cancellation of claims 1, 10, 16, 17, 21, 22, 25-28, and 30. This document will be critical for understanding the scope of the patent moving forward and for crafting any non-infringement or invalidity arguments for sustained claims.
• Monitor IPR2023-01036: Closely track the status of IPR2023-01036 at the USPTO PTAB E2E portal. The Final Written Decision is due by 2024-12-18. Its outcome could further narrow the patent's scope.
• Monitor CAFC Appeal 25-1466: Keep an eye on the Federal Circuit's docket for case 25-1466 (https://www.cafc.uscourts.gov/opinions-orders). The disposition of this appeal will determine the finality of the PTAB's cancellation of claims from IPR2024-00179.
• Evaluate Surviving Claims: For any claims that were sustained (not canceled in IPR2024-00179, or those that survive IPR2023-01036), conduct a fresh invalidity analysis using grounds not barred by estoppel.

Quote from IPR2024-00179 Final Written Decision (per search result summary):
"The Board determined claims 1, 10, 16, 17, 21, 22, 25, 26, 27, 28, and 30 are unpatentable."

Inventors

• Terry Wright (Dow AgroSciences LLC)
• Justin Lira (Dow AgroSciences LLC)
• Donald Merlo (Dow AgroSciences LLC)
• Nicole Arnold (Dow AgroSciences LLC)

Original assignee

Dow AgroSciences LLC was the original assignee. Dow AgroSciences LLC was a wholly owned subsidiary of Dow Chemical Company, focused on agricultural chemicals and biotechnology, including developing herbicide-resistant crops. It is now part of Corteva Agriscience LLC, which is an operating company that ships products embodying claims related to herbicide-resistant seeds and agricultural solutions. Dow AgroSciences LLC is no longer an independent operating entity, having been merged into Corteva Agriscience LLC.

Assignment timeline

There are no recorded post-issuance assignments for US10947555 on the USPTO Assignment Center. The "Current Assignee" information on Google Patents (Corteva Agriscience LLC) appears to be a result of a name change or corporate restructuring rather than a separate recorded assignment specific to this patent. Google Patents itself notes the event as a "reassignment" with the context "CHANGE OF NAME" from Dow AgroSciences LLC to Corteva Agriscience LLC.

Timeline diagram

timeline
    title Ownership of US 10947555
    2016 : Application filed by Dow AgroSciences LLC
    2021 : Issued to Dow AgroSciences LLC
    2021 : Assigned to Corteva Agriscience LLC via name change
    2026 : Patent expired

NPE / troll-pattern signals

1. Shell-entity transfer — Not present. The transfer from Dow AgroSciences LLC to Corteva Agriscience LLC is a result of a corporate name change/reorganization, not a transfer to a shell entity. Corteva Agriscience LLC is an operating company.
2. Known asserter in the chain — Not present. Neither Dow AgroSciences LLC nor Corteva Agriscience LLC are identified as known NPEs.
3. Repeat correspondent across the chain — Not present. There are no multiple recorded assignments to observe a pattern.
4. Cascading transfers — Not present. There is no chain of multiple assignments.
5. Pre-litigation transfer — Not present. The corporate name change to Corteva Agriscience LLC occurred on 2021-11-08, while the first district court litigation (1:22-cv-01046) was filed on 2022-08-09. This is outside the 6-month window to be considered "pre-litigation transfer" for enabling assertion.
6. Bankruptcy fire-sale — Not present. There is no indication of bankruptcy proceedings for Dow AgroSciences LLC related to this patent transfer.
7. Privateering — Unclear. While Corteva Agriscience LLC is an operating company, the nature of its litigation activities (as evidenced by the District Court and IPR cases) would require further investigation to determine if it aligns with a privateering model where an operating company transfers patents to an NPE to assert on its behalf. However, the ownership remains with an operating entity.
8. Defensive aggregator (anti-NPE) — Not present. The patent is currently held by an operating company, not a defensive aggregator.

Verdict

Operating-company assertion. The patent remains with Corteva Agriscience LLC, an operating company formed from the merger of Dow AgroSciences LLC, which was the original assignee. While the patent has been involved in litigation, the ownership chain does not show transfers to known shell entities or other typical NPE signals. The change from Dow AgroSciences LLC to Corteva Agriscience LLC is a corporate restructuring, not a transfer for assertion purposes to a non-operating entity.

Verification: https://assignmentcenter.uspto.gov/ (Search for patent number 10947555).

To identify the most relevant prior art for US patent 10947555, I will examine the patent citations. The prompt previously noted that the IPR2024-00179 petition challenged claims 1-3, 5-9, 11-13, 15-18, 20, 22-26, and 28-30 based on obviousness over combinations of prior art, including U.S. Patent No. 5,608,147 (Lyon '147), U.S. Patent Publication No. 2005/0022271 (Castle), U.S. Patent No. 6,153,401 (Monson), Streber et al., Westendorf et al., and Hunkapiller et al. I will focus on these specific references as they were explicitly deemed relevant enough to challenge the patent's validity in an IPR.

Here's an analysis of the most relevant prior art for US patent 10947555:

Cited U.S. Patents and Publications:

• U.S. Patent No. 5,608,147 (Lyon '147)

  • Full Citation: US5608147A.
  • Publication/Filing Date: Granted March 4, 1997. The priority date for the underlying application appears to be earlier, given its grant in 1997. The US10947555 patent itself refers to "U.S. Pat. No. 5,608,147" in the context of tfdA being used for 2,4-D resistance in dicot plants.
  • Brief Description: This patent generally relates to genetically engineered plants with enhanced resistance to phenoxy auxin herbicides like 2,4-D. It describes the use of a tfdA gene from Alcaligenes eutrophus (now Ralstonia eutropha) to provide this resistance. The patent details methods for transforming plants, particularly dicots, to express the tfdA gene, leading to the detoxification of 2,4-D within the plant.
  • Potentially Anticipated Claims: Lyon '147 potentially anticipates claims related to genetically modified plants or plant cells exhibiting 2,4-D resistance through the expression of an herbicide-degrading enzyme. Specifically, claims 1, 10, 16, 17, 21, 22, 25-28, and 30, which broadly cover methods of weed control using such plants, the transgenic plants/cells, nucleic acid molecules, and vectors, could be anticipated in part, especially concerning 2,4-D resistance. The IPR2024-00179 specifically challenged these claims, in part, over Lyon '147.

• U.S. Patent Publication No. 2005/0022271 (Castle)

  • Full Citation: US20050022271A1.
  • Publication/Filing Date: Published January 27, 2005. The priority date would be earlier, likely in 2004, given the publication date. The US10947555 patent itself refers to "US20050022271A1" in its citation list.
  • Brief Description: This publication describes compositions and methods for conferring herbicide resistance to plants, specifically focusing on synthetic auxin herbicides such as 2,4-D. It discusses novel genes and proteins that provide resistance to these herbicides. While the specific genes mentioned would need detailed analysis, the general subject matter of creating 2,4-D resistant transgenic plants is highly relevant.
  • Potentially Anticipated Claims: Similar to Lyon '147, Castle potentially anticipates claims 1, 10, 16, 17, 21, 22, 25-28, and 30, particularly those pertaining to 2,4-D resistance in plants. Its discussion of novel genes for herbicide resistance would be relevant to the novelty of the AAD-1 gene and its application.

• U.S. Patent No. 6,153,401 (Monson)

  • Full Citation: US6153401A.
  • Publication/Filing Date: Granted November 28, 2000.
  • Brief Description: This patent is directed to methods and compositions for conferring glyphosate tolerance to plants. While US10947555 focuses on 2,4-D and AOPP resistance, it also discusses stacking AAD-1 with other herbicide resistance genes, including glyphosate resistance. Monson would be relevant as a teaching for achieving glyphosate resistance, which could then be combined with the AAD-1 trait.
  • Potentially Anticipated Claims: Monson could potentially anticipate aspects of claims 1 and 10, for example, if the concept of combining herbicide resistance traits (specifically with glyphosate tolerance) is considered. It may also be relevant to the broader concept of generating multi-herbicide tolerant plants as described in the background and broader claims of US10947555.

Cited Non-Patent Literature:

• Streber et al. (1989)

  • Full Citation: Streber, W. R., et al. (1989). "Transgenic tobacco plants expressing a bacterial detoxification gene are resistant to 2,4-dichlorophenoxyacetic acid." Bio/Technology, 7(5), 450-454.
  • Publication/Filing Date: May 1989.
  • Brief Description: This publication describes the successful introduction of the tfdA gene from Alcaligenes eutrophus into tobacco plants, resulting in transgenic plants resistant to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D). This demonstrates an early example of engineering herbicide resistance in plants using a bacterial gene for detoxification.
  • Potentially Anticipated Claims: Streber et al. directly anticipates aspects of claims 1, 10, 16, 17, 21, 22, 25-28, and 30, particularly regarding the concept of using a bacterial gene to confer 2,4-D resistance in plants. It provides foundational knowledge for the genetic engineering of herbicide-tolerant crops.

• Lyon et al. (1989)

  • Full Citation: Lyon, B. R., et al. (1989). "Transgenic tobacco plants with enhanced resistance to the herbicide 2,4-dichlorophenoxyacetic acid." Plant Molecular Biology, 13(5), 575-580.
  • Publication/Filing Date: October 1989.
  • Brief Description: Similar to Streber et al., this paper reports on the successful engineering of tobacco plants for 2,4-D resistance using a gene encoding a 2,4-D degrading enzyme. This further solidifies the prior art demonstrating the feasibility of such an approach.
  • Potentially Anticipated Claims: Lyon et al. (1989) is highly relevant to claims 1, 10, 16, 17, 21, 22, 25-28, and 30, specifically those relating to transgenic plants and methods for conferring 2,4-D resistance.

• Lyon et al. (1993)

  • Full Citation: Lyon, B. R. (1993). "The use of the tfdA gene from Alcaligenes eutrophus for the generation of 2,4-D resistant plants." In Vitro Cellular & Developmental Biology-Plant, 29(1), 17-21.
  • Publication/Filing Date: January 1993.
  • Brief Description: This article provides an overview of the use of the tfdA gene for developing 2,4-D resistant plants, further detailing the work initiated in earlier publications. It confirms the established nature of using tfdA for 2,4-D resistance.
  • Potentially Anticipated Claims: This reference continues to be relevant to claims 1, 10, 16, 17, 21, 22, 25-28, and 30, reinforcing the state of the art regarding 2,4-D resistance in plants.

• Westendorf et al. (2002)

  • Full Citation: Westendorf, C., et al. (2002). "A novel 2,4-dichlorophenoxyacetate/alpha-ketoglutarate dioxygenase from Sphingobium herbicidovorans." Applied and Environmental Microbiology, 68(11), 5821-5827.
  • Publication/Filing Date: November 2002.
  • Brief Description: This paper describes the isolation and characterization of a new 2,4-D/alpha-ketoglutarate dioxygenase, rdpA, from Sphingobium herbicidovorans. This enzyme is distinct from previously known tfdA proteins and is identified as having low homology (28% amino acid identity) to tfdA. The patent text itself states that the AAD-1 gene (SEQ ID NO:3) is derived from Sphingobium herbicidovorans and is related to rdpA. This makes it highly relevant for the AAD-1 gene itself.
  • Potentially Anticipated Claims: Westendorf et al. (2002) is a primary piece of prior art for the AAD-1 gene (initially referred to as rdpA) and its biochemical activity in degrading 2,4-D. This directly impacts claims 1, 10, 16, 17, 21, 22, 25-28, and 30, which relate to the AAD-1 gene and protein, especially concerning its ability to degrade 2,4-D.

• Westendorf et al. (2003)

  • Full Citation: Westendorf, C., et al. (2003). "Characterization of the (R)-dichlorprop- and 2,4-dichlorophenoxyacetate-degrading enzyme RdpA from Sphingobium herbicidovorans." Applied and Environmental Microbiology, 69(10), 6000-6004.
  • Publication/Filing Date: October 2003.
  • Brief Description: This publication further characterizes the RdpA enzyme, showing its ability to catalyze the first step in the mineralization of both (R)-dichlorprop (a phenoxypropionic acid) and 2,4-D (a phenoxyacetic acid). This reference is crucial as it identifies the dual substrate specificity for phenoxyacetic and phenoxypropionic acids, laying the groundwork for the claims of US10947555 that highlight AAD-1's activity on both phenoxy auxins and AOPP herbicides.
  • Potentially Anticipated Claims: Westendorf et al. (2003) is highly relevant to claims 1, 10, 16, 17, 21, 22, 25-28, and 30, particularly those emphasizing the ability of the AAD-1 protein to provide resistance to both phenoxy auxin (like 2,4-D) and aryloxyphenoxypropionate (AOPP) herbicides. It discloses the core functional characteristics of the enzyme that forms the basis of the patent.

• Hunkapiller et al. (1989)

  • Full Citation: Hunkapiller, M., et al. (1989). "Large-scale DNA sequencing by automated fluorescent detection of dideoxynucleotides." Nature, 337(6202), 564-567.
  • Publication/Filing Date: February 9, 1989.
  • Brief Description: This publication describes methods for large-scale DNA sequencing using automated fluorescent detection. This reference is a general molecular biology technique paper.
  • Potentially Anticipated Claims: Hunkapiller et al. (1989) would not directly anticipate the core claims related to herbicide resistance genes or transgenic plants. Instead, it would be considered general knowledge in the field of molecular biology, relevant to the techniques used for cloning and sequencing the genes described in US10947555, but not to the inventive concept itself. It would likely be considered relevant to the "how-to" of the invention, but not the "what" or "why."

The obviousness of US patent 10947555 under 35 U.S.C. § 103 can be established by combining several prior art references, particularly those identified in the Inter Partes Review (IPR) proceedings. A person having ordinary skill in the art (POSA) at the priority date of April 30, 2004, would have been motivated to combine these references to achieve the claimed invention.

The core inventive concept of US10947555 revolves around the AAD-1 gene and the resulting AAD-1 protein (with at least 95% amino acid identity to SEQ ID NO:11), which confers resistance to both phenoxy auxin herbicides (like 2,4-D) and aryloxyphenoxypropionate (AOPP) herbicides in plants. The patent also describes plant-optimized versions of this gene and the stacking of this trait with other herbicide resistances like glyphosate tolerance.

Here's an analysis of relevant prior art combinations and the motivation for a POSA to combine them:

1. Combination for the AAD-1 Enzyme and its Dual Specificity:

• References: Westendorf et al. (2002) and Westendorf et al. (2003).
• Disclosure:
  • Westendorf et al. (2002) explicitly describes the isolation and characterization of a novel 2,4-D/α-ketoglutarate dioxygenase, named rdpA, from Sphingobium herbicidovorans. This enzyme was noted as being distinct from previously known tfdA proteins, having only 28% amino acid identity to tfdA from Ralstonia eutropha [cite: Westendorf et al., 2002]. The US10947555 patent itself states that AAD-1 (v1) is derived from Sphingobium herbicidovorans and is related to rdpA [cite: Westendorf et al., 2002].
  • Westendorf et al. (2003) further characterizes the rdpA enzyme, demonstrating its ability to catalyze the first step in the mineralization of both (R)-dichlorprop (a phenoxypropionic acid) and 2,4-D (a phenoxyacetic acid) [cite: Westendorf et al., 2003]. This publication, therefore, explicitly discloses the dual-specificity of the rdpA (AAD-1) enzyme for both phenoxyacetic and phenoxypropionic acid structures.
• Motivation for a POSA: A POSA would have recognized the importance of an enzyme capable of degrading two different classes of aryloxyalkanoate herbicides, as disclosed by Westendorf et al. (2003). The patent itself notes that "Aryloxyalkanoate chemical substructures are a common entity of many commercialized herbicides including the phenoxy auxins (such as 2,4-D and dichlorprop), pyridyloxy auxins (such as fluroxypyr and triclopyr), aryloxyphenoxypropionates (AOPP) acetyl-coenzyme A carboxylase (ACCase) inhibitors (such as haloxyfop, quizalofop, and diclofop)" [cite: AAD-1, Aryloxyalkanoate chemical substructures]. Given the disclosed activity of rdpA against phenoxypropionic acids, a POSA would have a reasonable expectation of success that this enzyme could also act on other aryloxyalkanoate structures, specifically aryloxyphenoxypropionates (AOPP herbicides), due to their shared structural features. The continued need for novel herbicide resistance mechanisms would motivate a POSA to explore such an enzyme.

2. Combination for Transgenic Plants with Herbicide Resistance:

• References: Lyon '147, Streber et al. (1989), Lyon et al. (1989), Lyon et al. (1993), and Castle (2005) in combination with Westendorf et al. (2002, 2003).
• Disclosure:
  • Lyon '147, Streber et al. (1989), Lyon et al. (1989), and Lyon et al. (1993) collectively teach the established art of generating 2,4-D resistant transgenic plants by introducing bacterial tfdA-type genes. These references demonstrate the feasibility and methods for genetically engineering plants to express bacterial enzymes for herbicide detoxification [cite: TfdA, TfdA].
  • Castle (2005) further describes methods and compositions for conferring herbicide resistance to plants, focusing on synthetic auxin herbicides such as 2,4-D, demonstrating ongoing work and interest in this area [cite: Castle].
• Motivation for a POSA: With the identification of the rdpA (AAD-1) gene and its dual activity by Westendorf et al. (2002, 2003), a POSA would be strongly motivated to apply the well-known techniques for creating herbicide-resistant plants (as taught by Lyon '147, Streber et al., Lyon et al. (1989, 1993), and Castle (2005)) to this new enzyme. The goal would be to confer broad-spectrum resistance to both phenoxy auxin and AOPP herbicides in crops, which would address the increasing problem of weed resistance and the need for more robust weed control options. The expectation of success would be high given the established precedent of using bacterial dioxygenases for herbicide detoxification in transgenic plants.

3. Plant-Optimized Gene Expression:

• References: General knowledge in molecular biology, as acknowledged in US10947555, combined with the above.
• Disclosure: The patent itself discusses that "heterologous genes are more efficiently expressed in (the cytoplasm of) plant cells" and that re-designing a heterologous gene "for optimal expression, using codon bias more closely aligned with the target plant sequence, whether a dicot or monocot species" was an "additional step in the design of genes encoding a bacterial protein" [cite: Maize].
• Motivation for a POSA: Optimizing gene sequences for expression in a target host, such as adjusting codon bias for plant expression, was a routine molecular biology technique known to a POSA at the time of the invention. Given the goal of achieving effective herbicide resistance in transgenic plants, a POSA would naturally be motivated to optimize the rdpA (AAD-1) gene sequence for robust expression in plant systems to maximize the detoxification effect.

4. Stacking with Other Herbicide Resistance Traits:

• References: Monson (2000) combined with the above.
• Disclosure: Monson (2000) teaches methods and compositions for conferring glyphosate tolerance to plants [cite: Monson]. The US10947555 patent itself describes stacking AAD-1 with other herbicide resistance genes, including glyphosate resistance, to provide "broader and more robust weed control and herbicide resistance management options" [cite: the subject invention].
• Motivation for a POSA: The widespread adoption of glyphosate-tolerant crops and the emergence of glyphosate-resistant weeds created a clear motivation for a POSA to develop multi-herbicide tolerant crops. Combining the dual 2,4-D/AOPP resistance of AAD-1 with existing glyphosate tolerance (as taught by Monson) would be an obvious strategy to provide a comprehensive weed control solution, delaying the development of further herbicide resistance and offering greater flexibility to growers.

Conclusion:

A POSA, motivated by the ongoing challenges of weed control and the established success of genetic engineering for herbicide resistance, would have combined the teachings of:

1. Westendorf et al. (2002) and (2003) to identify the rdpA (AAD-1) enzyme and recognize its dual activity against phenoxyacetic and phenoxypropionic acid structures (thereby suggesting activity against AOPP herbicides due to structural similarities).
2. Lyon '147, Streber et al. (1989), Lyon et al. (1989), Lyon et al. (1993), and Castle (2005) to apply established methods of transforming plants with bacterial genes to confer herbicide resistance.
3. General knowledge of molecular biology to optimize the rdpA gene for plant expression (e.g., codon optimization).
4. Monson (2000) to incorporate the newly conferred dual resistance with existing glyphosate resistance, thereby creating a plant with resistance to multiple herbicide classes.

The IPR2024-00179 Final Written Decision, which found claims 1, 10, 16, 17, 21, 22, 25, 26, 27, 28, and 30 unpatentable under 35 U.S.C. § 103(a) over combinations of these very references, further validates this obviousness analysis. [cite: PTAB case IPR2024-00179 filed (Final Written Decision)]

US patent 10947555B2, titled "Herbicide resistance genes," has an adjusted expiration date of January 14, 2026. This indicates that Patent Term Adjustment (PTA) or Patent Term Extension (PTE) may have been applied, as the statutory term for a patent filed in 2016 would typically extend to 2036. The patent has an "Expired - Lifetime" status as of the current date, June 24, 2026, consistent with this adjusted expiration date.

Here's a breakdown of the patent's term and related applications:

• Patent Term Adjustments (PTA): PTA is granted to compensate for certain delays caused by the USPTO during the prosecution of a utility or plant patent application. These delays can include the USPTO failing to:

  • Issue a first office action within 14 months of filing.
  • Respond to an applicant's reply or appeal within four months.
  • Issue a patent within four months after payment of the issue fee.
  • Issue a patent within 36 months from the filing date.
    The patent record explicitly states "Adjusted expiration, expires 2026-01-14," which suggests PTA was calculated and applied to the patent term. However, the specific details of the PTA calculation (e.g., A, B, or C delays, or applicant-caused delays) are not publicly detailed in the provided search results.

• Patent Term Extensions (PTE): PTEs are granted for patents on certain human drugs, medical devices, animal drugs, veterinary biological products, and food or color additive products to restore time lost during premarket government approval from a regulatory agency. There is no information in the provided search results to indicate that US10947555B2 has received a Patent Term Extension under 35 U.S.C. § 156. Such extensions are typically for pharmaceutical or similar regulated products, and while the patent deals with herbicide resistance genes for crops, it does not fall into these categories as per the available information.

• Continuation and Divisional Applications: The patent document mentions "Other versions" and lists US20170022515A1 as a related version. This typically refers to published applications, which can include continuation, divisional, or continuation-in-part applications.

  • US20170022515A1 is a publication of an earlier application. Its publication date is 2017-01-26, and its filing date is the same as US10947555B2 (2016-10-07), indicating it is likely an earlier publication of the same application that matured into US10947555B2, or a continuation/divisional thereof, with its own specific claims.
  • The patent also lists "Priority to US17/143,824" (2021-01-07) and "Priority to US17/175,966" (2021-02-15) and "Priority to US17/403,476" (2021-08-16). These are likely related applications, such as continuations or divisionals, claiming priority back to the original filing date of US10947555B2 (or its parent). Without further investigation into these application numbers, their exact nature (continuation, divisional, or CIP) cannot be definitively stated from the provided information.

• Related Family Members: Beyond the identified priority applications (US17/143,824, US17/175,966, US17/403,476), the provided information also includes the publication US20170022515A1. The term "family members" typically refers to all patents and applications related by priority claims.

• Projected Expiration Date: The Google Patents entry explicitly states the patent's "Adjusted expiration, expires 2026-01-14." Given today's date (June 24, 2026), the patent is indicated as "Expired - Lifetime." This is the projected and actual expiration date, taking into account any patent term adjustments.

Defensive Disclosure for US Patent 10947555B2

This Defensive Disclosure document aims to broaden the publicly available prior art surrounding US Patent 10947555B2, "Herbicide resistance genes," thereby rendering future incremental improvements or variations in this technological space obvious or non-novel. The focus is on generating detailed derivative variations of the claimed invention.

---

Derivative Variations for Independent Claim 1

Claim 1: A transgenic plant cell that is resistant to 2,4-D and aryloxyphenoxypropionate (AOPP) herbicides, said transgenic plant cell comprising a plant-optimized nucleic acid encoding an aryloxyalkanoate dioxygenase (AAD-1) polypeptide having at least 95% amino acid sequence identity to SEQ ID NO: 11, wherein said AAD-1 polypeptide degrades 2,4-D and AOPP herbicides.

1. Material & Component Substitution

Derivative 1.1: Alternative Herbicide Degradation Pathway via P450 Monooxygenases and Conjugation

• Enabling Description: A transgenic plant cell engineered for resistance to 2,4-D and AOPP herbicides, where the degradation mechanism relies on a heterologous cytochrome P450 monooxygenase (e.g., from the CYP71B family or similar xenobiotic-metabolizing P450s) capable of hydroxylating the aryloxyalkanoate side chain, followed by conjugation with glutathione, sugars, or amino acids catalyzed by plant endogenous or heterologously expressed glutathione S-transferases (GSTs) or glycosyltransferases (GTs). The plant-optimized nucleic acid would encode the specific P450 enzyme (e.g., a variant of CYP71B1 or a newly identified bacterial P450 with such activity, codon-optimized for plant expression), and potentially an enhanced conjugating enzyme, leading to detoxification of both 2,4-D and AOPP herbicides. This mechanism provides an alternative to dioxygenase activity.

graph TD
    A[Phenoxy Auxin / AOPP Herbicide] --> B{P450 Monooxygenase (plant-optimized gene)};
    B --> C[Hydroxylated Metabolite];
    C --> D{GST / Glycosyltransferase (endogenous or enhanced)};
    D --> E[Conjugated Metabolite];
    E --> F[Detoxified / Inactive];
    F --> G(Resistant Plant Cell);

Derivative 1.2: AAD-1 Orthologs with Broader Sequence Identity Ranges

• Enabling Description: A transgenic plant cell comprising a plant-optimized nucleic acid encoding an aryloxyalkanoate dioxygenase (AAD-1) polypeptide derived from bacterial orthologs or synthetic variants exhibiting dual 2,4-D and AOPP degradation activity, but possessing amino acid sequence identity to SEQ ID NO: 11 within the range of 60% to 94% (e.g., 65%, 70%, 75%, 80%, 85%, 90%). These orthologs can be sourced from diverse microbial genera (e.g., Sphingomonas, Burkholderia, Variovorax) identified through sequence homology searches or functional metagenomics screening. The nucleic acid encoding these variant AAD-1 enzymes would be codon-optimized for expression in the target plant cell (e.g., maize, soybean, cotton), ensuring efficient translation and functional activity in planta.

classDiagram
    class AAD-1_SEQ_ID_NO_11 {
        +amino_acid_sequence: string
        +degrades_2_4_D(): bool
        +degrades_AOPP(): bool
    }
    class AAD-1_Ortholog {
        +amino_acid_sequence: string
        +identity_to_SEQ11: float
        +degrades_2_4_D(): bool
        +degrades_AOPP(): bool
    }
    class PlantCell {
        +optimized_nucleic_acid: string
        +expresses_AAD1_polypeptide(): bool
        +is_2_4_D_resistant(): bool
        +is_AOPP_resistant(): bool
    }
    AAD-1_Ortholog "1" -- "1" AAD-1_SEQ_ID_NO_11 : similar_to
    PlantCell "1" -- "1" AAD-1_Ortholog : encodes

Derivative 1.3: Ribozyme-Based Herbicide Inactivation in Transgenic Plant Cells

• Enabling Description: A transgenic plant cell resistant to 2,4-D and AOPP herbicides, achieved by introducing a plant-optimized nucleic acid sequence that transcribes into a catalytic RNA molecule (ribozyme) or a deoxyribozyme (DNAzyme). This ribozyme/DNAzyme is specifically designed to cleave or chemically modify the herbicide molecules directly (e.g., hydrolyze ester bonds of AOPP esters, or disrupt the phenoxy linkage of 2,4-D) or target the mRNA of essential plant enzymes involved in the herbicidal mode of action (e.g., ACCase mRNA for AOPPs) only in the presence of the herbicide. The nucleic acid sequence would be optimized for plant expression, including appropriate promoters and terminators, to ensure high intracellular concentrations of the catalytic RNA/DNA.

flowchart TD
    A[Herbicide (2,4-D / AOPP)] --> B{Transgenic Plant Cell};
    B -- Nucleic Acid --> C[Transcription];
    C --> D[Ribozyme / DNAzyme];
    D -- Catalytic Action --> E[Inactivated Herbicide];
    E --> F(Resistant Phenotype);

2. Operational Parameter Expansion

Derivative 1.4: Ultra-High-Capacity AAD-1 Expression for Extreme Herbicide Loads

• Enabling Description: A transgenic plant cell engineered to exhibit resistance to 2,4-D and AOPP herbicides at concentrations significantly exceeding typical field application rates (e.g., 5-50x the highest recommended dose). This is achieved by incorporating multiple copies of the plant-optimized AAD-1 nucleic acid (SEQ ID NO: 11 or a variant with enhanced kinetic properties) into the plant genome, driven by ultra-strong constitutive or herbicide-inducible promoters (e.g., super-promoter systems, tandem promoter repeats, or synthetic promoters designed for maximal expression). Additionally, the AAD-1 polypeptide can be engineered for enhanced stability and reduced turnover within the plant cell, ensuring sustained high-level enzymatic activity under conditions of extreme herbicide pressure.

sequenceDiagram
    participant PC as Plant Cell
    participant NH as Noxious Herbicide (Extreme Load)
    participant GT as AAD-1 Gene Tandem Repeats
    participant SP as Strong Promoter
    participant A1 as AAD-1 Polypeptide (High Stability)

    NH->>PC: Apply extreme herbicide concentration
    SP->>GT: Constitutive/Inducible activation
    GT->>PC: High-level Transcription
    PC->>A1: Abundant Translation
    A1->>NH: Rapid & Efficient Degradation
    NH--xPC: Herbicide rendered ineffective
    PC->>PC: Plant Cell maintains viability

Derivative 1.5: Thermotolerant AAD-1 for Resistance in High-Temperature Climates

• Enabling Description: A transgenic plant cell engineered for herbicide resistance, particularly in agricultural regions characterized by high ambient temperatures (e.g., 35-50°C). This plant cell comprises a plant-optimized nucleic acid encoding a variant AAD-1 polypeptide (derived from thermophilic microorganisms or engineered through directed evolution of SEQ ID NO: 11) that exhibits enhanced thermal stability and optimal catalytic activity at elevated temperatures. The protein engineering focuses on increasing the melting temperature (Tm) and reducing aggregation at high temperatures through modifications in amino acid composition (e.g., increased disulfide bonds, enhanced hydrophobic packing, introduction of stabilizing motifs) while retaining dual 2,4-D and AOPP degradation capabilities.

stateDiagram-V2
    state "Normal_Condition_Cell" as NC
    state "High_Temperature_Stress" as HTS
    state "Resistant_Cell_High_Temp" as RCHT
    state "AAD-1_Functional" as AF
    state "AAD-1_Denatured" as AD

    NC --> HTS: Environmental shift (>35°C)
    HTS --> RCHT: Expresses Thermotolerant AAD-1
    RCHT --> AF: AAD-1 remains active
    AF --> AF: Degrades 2,4-D & AOPP
    HTS --> AD: Wildtype AAD-1 denatures (not claimed)
    AD --> AD: Loss of resistance (not claimed)

Derivative 1.6: AAD-1 Expressing Plant Cells for Bioreactor Production

• Enabling Description: Transgenic plant cells, specifically selected and adapted for growth in large-scale suspension cultures (bioreactors), engineered to constitutively express high levels of the plant-optimized AAD-1 polypeptide (SEQ ID NO: 11 or an enhanced variant). These cells are optimized for rapid proliferation in liquid media, high protein yield, and efficient secretion or intracellular accumulation of the AAD-1 enzyme. The secreted AAD-1 protein can then be harvested from the culture medium for industrial applications (e.g., enzymatic bioremediation solutions), or the cells themselves can be used as biocatalysts for ex situ herbicide degradation in wastewater treatment streams.

flowchart LR
    A[Plant-Optimized AAD-1 Gene] --> B{Transfection into Plant Cell};
    B --> C{Selection & Callus Induction};
    C --> D{Suspension Culture Adaptation};
    D --> E(Bioreactor Cultivation);
    E -- AAD-1 Production --> F[Cell Harvest / Enzyme Extraction];
    F --> G[Industrial Application (e.g., Bioremediation)];

3. Cross-Domain Application

Derivative 1.7: Bioremediation of Herbicide-Contaminated Water Using AAD-1 Expressing Aquatic Plant Cells

• Enabling Description: Transgenic aquatic plant cells (e.g., from duckweed, Lemna minor, or other suitable macrophytes) comprising a plant-optimized nucleic acid encoding the AAD-1 polypeptide (SEQ ID NO: 11 or variant) that degrades 2,4-D and AOPP herbicides. These modified aquatic plant cells are specifically engineered for high expression and/or secretion of AAD-1 into the surrounding water, or for efficient uptake and intracellular degradation of the target herbicides. The application is for the ex situ or in situ bioremediation of agricultural runoff, industrial effluent, or contaminated water bodies containing phenoxy auxin and AOPP herbicide residues. The aquatic plants serve as living bioreactors, removing environmental pollutants.

flowchart TD
    A[Herbicide Contaminated Water] --> B{Aquatic Environment (Pond, Basin)};
    B --> C[Transgenic Aquatic Plant Cells];
    C -- Expresses AAD-1 --> D[Herbicide Uptake & Degradation];
    D --> E[Detoxified Water];
    C -- Biomass Accumulation --> F[Plant Biomass Removal];
    F --> G[Harvested AAD-1 (Optional)];

Derivative 1.8: AAD-1 Expressing Cells in Biosensors for Environmental Monitoring

• Enabling Description: Transgenic microbial cells (e.g., Saccharomyces cerevisiae, E. coli, or even non-photosynthetic plant cells grown in culture) comprising a plant-optimized nucleic acid encoding the AAD-1 polypeptide (SEQ ID NO: 11 or variant) for 2,4-D and AOPP degradation. These cells are further engineered to contain a reporter system (e.g., GFP, luciferase) whose expression is inversely proportional to the concentration of active herbicides. When exposed to 2,4-D or AOPP, the AAD-1 degrades the herbicide, leading to a measurable change in reporter activity (e.g., increased light emission or fluorescence) that signals the presence and quantity of active enzyme and/or the efficiency of degradation. This system is used in a portable biosensor device for rapid, real-time environmental detection and quantification of herbicide levels in water or soil samples.

graph LR
    A[Herbicide Sample] --> B{Biosensor Device};
    B --> C[Transgenic Microbial Cell];
    C -- AAD-1 Expression --> D{Herbicide Degradation};
    D --> E{Reporter System Activation};
    E --> F[Signal Detection (e.g., Fluorescence)];
    F --> G(Real-time Herbicide Level Readout);

4. Integration with Emerging Tech

Derivative 1.9: AI-Driven Codon Optimization and Promoter Design for Enhanced AAD-1 Expression

• Enabling Description: A transgenic plant cell containing an AAD-1 nucleic acid (encoding SEQ ID NO: 11 or a variant) where the codon usage, mRNA secondary structure, and associated promoter/enhancer elements have been de novo designed and optimized by an Artificial Intelligence (AI) algorithm. The AI model, trained on extensive plant transcriptome and proteome data, predicts the most efficient gene sequences and regulatory motifs for maximal AAD-1 expression, stability, and chloroplast/mitochondrial targeting (if desired) in a specific crop species (e.g., cotton). This AI-driven optimization aims to achieve expression levels and catalytic rates superior to empirically derived "plant-optimized" sequences, leading to ultra-robust herbicide resistance.

flowchart LR
    A[Plant Transcriptome/Proteome Data] --> B{AI Model Training};
    B --> C[Predict Optimal Codon/Promoter Sequences];
    C --> D{Synthesize AAD-1 Nucleic Acid (AI-Optimized)};
    D --> E[Transgenic Plant Cell Creation];
    E --> F(Enhanced Herbicide Resistance);

Derivative 1.10: IoT-Enabled Smart Farm Integration with AAD-1 Transgenic Plants

• Enabling Description: Transgenic plants (derived from Claim 1 cells) expressing AAD-1 (SEQ ID NO: 11 or variant) are cultivated in fields equipped with an Internet of Things (IoT) sensor network. This network continuously monitors environmental parameters (e.g., soil moisture, temperature, light intensity) and plant physiological responses (e.g., photosynthetic activity, stress markers). In response to detected weed pressure or predicted herbicide drift events (identified by remote sensing or localized sensors), an AI-driven farm management system within the IoT network dynamically adjusts herbicide application parameters (e.g., timing, concentration, specific herbicide type, even enabling application of 2,4-D and AOPP) to optimize weed control while minimizing environmental impact. The AAD-1 trait in the plants enables the flexible use of 2,4-D and AOPP under AI-informed decision-making.

graph TD
    A[Environmental Sensors (Soil, Weather)] --> B{Plant Physiological Sensors (Stress, Growth)};
    B --> C{Remote Sensing (Weed Detection)};
    C --> D{IoT Gateway & Cloud Platform};
    D --> E{AI-Driven Farm Management System};
    E -- Optimized Herbicide Application Strategy --> F[Automated Sprayers / Drones];
    F --> G[Transgenic AAD-1 Plants in Field];
    G --> H(Efficient Weed Control & Crop Protection);
    E -- Data Feedback --> D;

5. The "Inverse" or Failure Mode

Derivative 1.11: Inducible "Safe-Fail" AAD-1 for Controlled Resistance Termination

• Enabling Description: A transgenic plant cell where the plant-optimized nucleic acid encoding AAD-1 (SEQ ID NO: 11 or variant) is placed under the control of an inducible promoter system that can be precisely deactivated by a specific chemical signal (e.g., a small molecule repressor, or a hormone analogue). This design allows for the termination of AAD-1 expression and subsequent loss of herbicide resistance in planta at a desired developmental stage (e.g., prior to harvest to prevent gene flow or persistent environmental enzyme activity) or in specific tissues, acting as a "safe-fail" mechanism. This system ensures that the herbicide resistance trait is transient or spatially confined, addressing potential regulatory and environmental concerns regarding gene containment.

stateDiagram-V2
    state "AAD-1_Expressed_Resistant" as AER
    state "Inducible_Promoter_Active" as IPA
    state "Inducible_Promoter_Inactive" as IPI
    state "AAD-1_Degrading_Loss_Resistance" as ADLR

    [*] --> AER
    AER --> IPA: During growing season
    IPA --> AER: Continues degrading herbicides
    IPA --> IPI: Apply Repressor Compound
    IPI --> ADLR: AAD-1 expression terminates, existing protein degrades
    ADLR --> [*]: Loss of Resistance

Derivative 1.12: Low-Power AAD-1 for Sentinel Plants

• Enabling Description: A transgenic plant cell engineered with a plant-optimized nucleic acid encoding a hypoactive AAD-1 polypeptide variant (e.g., a version of SEQ ID NO: 11 with specific point mutations reducing catalytic efficiency by 70-90%). This "low-power" AAD-1 provides only minimal or partial resistance to 2,4-D and AOPP herbicides, allowing the plant cell to act as a sensitive bioindicator or "sentinel" for low-level herbicide exposure. The mild injury observed in these sentinel plants upon exposure to sub-lethal herbicide concentrations can trigger an internal signaling cascade (e.g., reporter gene activation, volatile organic compound emission) detectable by external sensors, indicating early environmental contamination without robust resistance for cultivation.

flowchart TD
    A[Sub-Lethal Herbicide Exposure] --> B{Transgenic Sentinel Plant Cell};
    B -- Hypoactive AAD-1 --> C[Partial Herbicide Degradation];
    C --> D[Mild Cellular Stress/Injury];
    D --> E[Activation of Internal Reporter (e.g., Fluorescent Protein)];
    E --> F[Detectable Signal (Optical/Chemical)];
    F --> G(Early Warning of Contamination);

---

Combination Prior Art Scenarios with Open-Source Standards

Here are three scenarios combining the principles of US Patent 10947555B2 with existing open-source standards, thereby generating new prior art that anticipates or renders obvious future incremental improvements.

Combination Prior Art Scenario 1: AAD-1 Gene Integration into BioBrick Standard Parts for Synthetic Biology Platforms

• Enabling Description: The plant-optimized nucleic acid sequence encoding the AAD-1 polypeptide (SEQ ID NO: 11 or variants thereof, with dual 2,4-D and AOPP degradation activity) is synthesized and formatted according to the BioBrick standard (e.g., RFC 10 or newer). This involves flanking the AAD-1 coding sequence with standard BioBrick restriction sites (e.g., EcoRI, XbaI, SpeI, PstI) and removing any internal conflicting restriction sites through silent mutations. This standardized AAD-1 BioBrick part is then made publicly available in an open-source registry (e.g., iGEM Registry of Standard Biological Parts) for easy assembly with other standard biological parts, such as various plant-specific promoters (e.g., CaMV35S BioBrick, Ubiquitin BioBrick) and terminators (e.g., NOS terminator BioBrick), to facilitate rapid construction of diverse plant expression vectors for herbicide resistance. This makes the engineering of AAD-1 into any plant via modular synthetic biology approaches obvious.

Combination Prior Art Scenario 2: Open-Source AI/Machine Learning Model for AAD-1 Codon Optimization Across Plant Species

• Enabling Description: An open-source AI/Machine Learning framework, based on publicly available libraries (e.g., TensorFlow or PyTorch), is developed and released. This framework includes a trained model that takes an AAD-1 polypeptide sequence (such as SEQ ID NO: 11 or any variant) and a target plant species' codon usage bias (sourced from public databases like NCBI Codon Usage Database, which adheres to OBO principles), and generates a highly plant-optimized nucleic acid sequence for maximal expression. The model considers factors beyond simple codon frequency, such as mRNA secondary structure, GC content, and avoidance of cryptic splice sites. The software, including the trained model and source code, is published under an open-source license (e.g., MIT License or Apache 2.0). This renders the sophisticated plant-optimization of AAD-1 genes (and indeed any transgene) an obvious task for anyone with access to public computational tools.

Combination Prior Art Scenario 3: Decentralized Autonomous Organization (DAO) for Community-Driven AAD-1 Trait Development and Stewardship

• Enabling Description: A decentralized autonomous organization (DAO) is established on a public blockchain platform (e.g., Ethereum with ERC-20 tokens). This DAO facilitates community-driven research and development of herbicide resistance traits, including further optimization, testing, and distribution of AAD-1 genes (such as those encoding SEQ ID NO: 11). Participants can contribute computational resources for AI-driven design, submit experimental data, or perform in planta trials. All intellectual property, including sequences, experimental results, and software (e.g., gene editing protocols, vector designs), are stored on a distributed ledger (blockchain) and made publicly accessible under open-source licenses. The DAO uses smart contracts for governance and incentive mechanisms, ensuring transparency and collective ownership of the developed herbicide resistance solutions, making advanced stewardship and development practices for traits like AAD-1 openly accessible and transparent.